Sacral Nerve Stimulation for Urinary Voiding Dysfunction, Fecal Incontinence and Constipation - (0404)

Cigna covers permanent sacral nerve stimulation (SNS) for urinary voiding dysfunction (urge incontinence, nonobstructive retention, overactive bladder) and for fecal incontinence, and considers SNS not medically necessary for other indications including constipation. Coverage requires a documented successful screening trial (PNE or staged trial) showing ≥50% improvement in reported symptoms, submission of the policy-listed CPT/HCPCS codes, and supporting medical records (baseline symptoms, trial parameters, and follow‑up).

"Permanent sacral nerve stimulation (SNS) implantation for the treatment of urinary voiding dysfunction (i."

Sign up to see full coverage criteria, indications, and limitations.